Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.
about
Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikisUrokinase receptor and resistance to targeted anticancer agentsIdentification of uPAR-positive chemoresistant cells in small cell lung cancerNeutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptorEctodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in micePreparation of pre-confluent retinal cells increases graft viability in vitro and in vivo: a mouse modelUrokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cellsSerum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavageNovel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance.Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancersThe DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expressionRegulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by AktLeukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease.Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Translational initiatives in thrombolytic therapy.Opposite modulation of cell migration by distinct subregions of urokinase connecting peptide.Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cellsA doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines.Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis.D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic Pseudomonas aeruginosa induces anoikis of human vascular cells.LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway.
P2860
Q24316639-69D67219-38F6-4B11-BF1D-4571A8D5596AQ26797385-0C60651D-76B9-4B46-9B6D-3963F8CF8873Q28469143-075DCC66-9BF2-4066-BA01-4E315DE2E7E2Q30361219-617D0432-1C24-4669-8F87-D0F4BB5F4D2EQ30443804-D83D9545-D960-48C0-8DC6-5D6939E8030CQ30493647-17FD3789-A733-4A67-B2F1-311EDCEC1615Q30495814-BFA1AD6D-823D-4004-BBBA-B1299382648BQ33954821-EC1FBA13-B731-42EE-AB7B-3329ED2D6E43Q34117636-9B6FCBB3-6C63-4211-95DE-8D8C6729E48DQ34370103-288AAFAD-9F02-4E77-BBF5-7B24201D8939Q34999718-4BDD9D8F-DD1B-429E-8041-503DF0461CA5Q35017844-F50C1142-27A2-4AF0-B965-BBBCC8829E8DQ35677625-94B729DE-6C93-4854-8B96-1B6FCC8C8D80Q35966228-88B065D1-4501-4927-A080-E20C0E6937E7Q36484510-4350E343-7091-4410-B27A-9D1BAE2F9258Q36715904-C1E23311-CB27-4588-A974-D8B0CA2B2388Q36821154-B05ACEF0-A26C-4D85-9F75-91E1E8E87EDCQ36951585-095B375E-E0D1-48E1-AB3F-FFF9CB4DFAB4Q36980771-B0379AC9-F848-46EA-BA18-F8B0A4093B63Q37801943-1BAF30D2-E640-4B6E-B4B1-5F86DAFD6C4BQ39100187-5A34E314-77D3-4654-B081-9A9E098B1B39Q39177238-B1CEC850-D7B1-4C34-A67A-DCBC5D577C27Q39827857-9B3CF7B1-23BF-4D96-89F1-6858E2C97140Q39988571-AF207394-E068-453E-98DC-4A9A1FA5C918Q40131728-3933BDDD-9A9A-411A-883F-676809036880Q43097641-F7DD3C08-CBB4-4BEC-9294-2F6B0FDF0EBEQ48220228-23ABD95B-A427-486C-BC16-C10806C3B4B3Q50201202-0AE75145-DE65-4E44-BC23-337579D1AA2DQ51779283-0B61A444-279D-432B-9D6D-7C1E49A976E2Q52610170-30ED382F-4B9A-4668-B8BF-5DFEAF9B3178Q52822414-7BA40DF8-5E9E-4472-A686-73E004C1BFEC
P2860
Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Urokinase signaling through it ...... sing BCL-xL expression levels.
@en
type
label
Urokinase signaling through it ...... sing BCL-xL expression levels.
@en
prefLabel
Urokinase signaling through it ...... sing BCL-xL expression levels.
@en
P2860
P356
P1476
Urokinase signaling through it ...... sing BCL-xL expression levels.
@en
P2093
Daniela Alfano
M Patrizia Stoppelli
P2860
P304
17758-17767
P356
10.1074/JBC.M601812200
P407
P577
2006-04-21T00:00:00Z